Pathway enrichment analysis (FDR < 0.05) of these potential target genes revealed predominantly signaling molecules that represent direct P53 effectors and play a role in pathways in cancer, cell cycle and the E2F transcription factor network (Tables 5 and 6). The gene discussed is TP53; the disease is cancer.